HIF1A and glioblastoma: Treatment of LN229 glioblastoma cells with CoCl2, a chemical hypoxia inducer that stabilizes HIF-1α/HIF-2α under normoxic conditions [40], resulted in a dose- and time-dependent increase in SAMD9 protein levels (Fig. 4a, b).